SUN05 Controversies Regarding Surgery and Radiation in Merkel Cell Carcinoma Management
DESCRIPTION
During this session, we will comprehensively address controversial areas in the management of locoregional Merkel cell carcinoma (MCC), relying on up-to-date data and expert panel opinions. We will begin by outlining standard staging procedures and treatment recommendations. Next, we will delve into the evolving landscape of surgical options, including the nuances of narrow versus wide local excision, as well as the utility of Mohs micrographic surgery. This discussion will extend to the indications for sentinel lymph node biopsy and postoperative radiation therapy. Lastly, we will introduce the emerging paradigm of hypo-fractionated radiation therapy. Our expert panel will provide practical tips for tailoring optimal treatment plans that align with individual patient requirements.
LEARNING OBJECTIVES
Summarize the standard treatment options of locoregional Merkel cell carcinoma staging and therapy.
Describe the advantages and drawbacks of wide local excision, Mohs surgery, and radiation therapy.
Apply tailored, ideal treatment regimens to meet specific patient needs.
SCHEDULE
2:30 PM
Overview of locoregional Merkel cell carcinoma treatment options
Paul Nghiem, MD, PhD, FAAD
2:45 PM
Surgical excision of Merkel cell carcinoma
3:00 PM
Radiation therapy for Merkel cell carcinoma
3:15 PM
Panel Discussion, Q&A
SPEAKERS
Martha Laurin Council, MD, MBA, FAAD
Division of Dermatology, Washington University
Peter Goff
Seattle VA Medical Center; UW & FHCC Radiation Oncology
Paul Nghiem, MD, PhD, FAAD
Dept of Dermatology; Univ of WA
Song Park, MD, IFAAD
SPEAKER DISCLOSURES
Martha Laurin Council, MD, MBA, FAAD
Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Peter Goff
No financial relationships exist with ineligible companies.
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Song Park, MD, IFAAD
EMD Serono – Speaker(Honoraria);